REMEDi4ALL has established a funders network, led by ZonMw and in collaboration with the Anticancer Fund, dedicated to advancing Drug Repurposing initiatives.
The purpose of the REMEDi4ALL Funders Network is to enhance high impact drug repurposing research. It comprises diverse funding entities – both public and private – from across the globe that are dedicated to advancing drug repurposing initiatives.
Our objectives are to:
- facilitate collaboration among all types of funding entities and promote collaboration with research institutions and other stakeholders;
- reduce fragmentation of the drug repurposing funding landscape by supporting the alignment of research agendas, facilitating coordination of funding activities, and supporting joint calls;
- create innovative funding streams and explore viable business models;
- share best practices and learnings among funders;
- connect funders with investigators and projects that run through the REMEDi4ALL platform, including opportunities for joint funding;
- support high-impact & patient-centric project;
- enhance research quality;
- find solutions for funding barriers;
- advocate for policy changes at national and international levels, including changes in regulatory approval pathways, reimbursement and HTA processes.
Become a member
All funding entities both public and private can become members. In case you are not a funder you can become an observer. There is currently no legal or financial commitment required to become a member or observer. Find more information about the background, objectives, membership, principles, and governance of the REMEDi4ALL Funders Network in our charter. To become a member or observer please complete the application form and send it with a logo of your organisation to REMEDi4ALL@zonmw.nl.
Resources
- Overview of drug repurposing calls: Funding calls database
- Training opportunities: Learning resources database
- Interactive guide on creating (joint) funding calls: A practical guide to creating joint funding calls for impactful drug repurposing research
- Value assessment criteria & selection tool: Framework for judging the project value of repurposed medicines
Upcoming & past events
- Funders Network Meeting Brussels – May 2026
- Webinar – Working with Regulators: Pre-grant scientific advice – February 2026
- REMEDi4ALL Marketplace Meeting – November 2025
- Webinar – Reaching Patients Broadly: Case Studies – October 2025
- Online workshop – Value assessment framework – July 2025
- Funders Network Meeting Amsterdam – May 2025
- Online workshop – Funding landscape and (longitudinal) co-funding– June 2024
- Funders Network Meeting Barcelona – March 2024
- Online workshop – REMEDi4ALL: What’s in it for Funders? – July 2023
REMEDi4ALL Marketplace
The REMEDi4ALL Marketplace is designed to bring funders and project developers together in an environment that maximises the chances of a successful and fruitful match.
By offering funders the chance to be matched with optimally designed and managed repurposing projects, the REMEDi4ALL marketplace supports and enables the opportunity for end-to end co-funding of projects, enabling faster routes to patients and market.
Discover more about the marketplace here.
Funders Network webinar series
The Funders Network webinar series brings together leaders and innovators to exchange best practices, explore shared challenges, and strengthen our collective ability to drive patient access to repurposed medicines across Europe and beyond. Curious to learn more or join an upcoming session? Get in touch: REMEDi4ALL@zonmw.nl.
Working with Regulators: Pre-grant scientific advice
Mon 2 Feb 2026
In this webinar, funders and regulators discussed the importance of pre-grant regulatory scientific advice (PGRSA) and its integration into funding processes for drug repurposing initiatives, based on two real world examples and the regulatory initiative IncreaseNET.
Reaching Patients Broadly: Case Studies
Tue 14 Oct 2025
In this session, Barbara Goodman (Cures Within Reach) and Hans Platteeuw (Galenicap) present several funded repurposing cases that have successfully reached patients. They share key insights and lessons learned, followed by an interactive discussion with the Network.
To receive the latest REMEDi4ALL related news and opportunities: Subscribe to the REMEDi4ALL Newsletter
Membership
REMEDi4ALL Partners & Associated partners
